Skip to content

We are supported by referral fees from the advertisers presented on this site. We do not present information about every advertiser or offer available.

Semaglutide.now
Semaglutide

SkinnyRx vs Embody: Oral semaglutide vs low-cost compounded options

Quick verdict: SkinnyRx is geared toward people who want oral semaglutide with FSA/HSA flexibility and fast overnight delivery, while Embody is for cost-driven patients seeking low entry pricing and fast 1–2 day shipping. Both prescribe compounded GLP-1 products after an online clinician review.

Explore SkinnyRx oral semaglutide from $249/mo

SkinnyRx vs Embody: price, format, and who they serve

The primary differences between SkinnyRx and Embody are price and delivery format. SkinnyRx promotes daily compounded semaglutide tablets starting at as low as $249/mo and highlights FSA/HSA eligibility and free overnight shipping. Embody advertises compounded semaglutide for $69/month (was $299) with free shipping and 1–2 day delivery and also offers compounded tirzepatide at $119/month. Early verdict: choose SkinnyRx if FSA/HSA eligibility and an oral tablet matter; choose Embody if the lowest monthly cash price is the priority.

Price and value comparison

SkinnyRx: As low as $249/mo for daily oral semaglutide tablets. SkinnyRx also emphasizes FSA/HSA eligibility and the ability to use pre-tax dollars, plus split payments via Affirm as an option. Embody: $69/month for compounded semaglutide (reduced from $299) and $119/month for compounded tirzepatide, positioned as one of the lowest entry prices in the space. Embody states flat locked-in monthly pricing with no monthly membership or long-term commitment. Both note that pricing can depend on clinician recommendation or may be limited-time offers; Embody specifically says the $69 price is a limited-time offer that may increase.

See Embody pricing at $69/mo

Form and administration: oral tablet vs compounded injections

SkinnyRx offers daily oral semaglutide tablets taken under the tongue as an alternative to injections. Their materials state tablets are designed with clinically supported ingredients and are an oral form of the same medication used in GLP-1 injections. Embody offers compounded semaglutide and tirzepatide injections and positions itself as a telehealth provider that prescribes compounded GLP-1s after a clinician review. If you prefer a daily tablet format, SkinnyRx is the only one of the two that lists oral semaglutide tablets.

Shipping speed and fulfillment

Both providers advertise fast shipping but with different specifics. SkinnyRx promotes free overnight shipping on all orders and says customers receive shipping and tracking information within 2 business days after prescription processing. Embody advertises free shipping with delivery in 1–2 days after clinician approval and emphasizes fast fulfillment as part of its value proposition. Both require a licensed provider review and clinician approval before shipment.

Get SkinnyRx with overnight shipping

Support, monitoring, and program features

SkinnyRx highlights personalized care, ongoing support, and dose adjustments by licensed providers, plus access to a patient care team and providers for questions. Embody presents a lean model: prescription and telemed visits included, 24/7 support access for dosing and side-effect questions, and no membership fees. Embody notes fewer premium features such as integrated coaching or advanced monitoring compared with higher-priced platforms. Both platforms require an online clinician review before prescribing compounded medication.

Safety, testing, and regulatory notes

Both providers offer compounded medications. SkinnyRx states partner pharmacies perform third-party testing through FDA- and DEA-compliant labs every 3 to 6 months, confirming concentration within plus or minus 10 percent of the active ingredient, and explicitly notes that compounded drugs are not FDA-approved or evaluated for safety, effectiveness, or quality by the FDA. Embody likewise notes that its compounded medications are not FDA-approved finished products but use the same active ingredients as branded GLP-1s and that compounded meds are not FDA-reviewed. Both require prescriptions and clinician review; neither supplies branded Ozempic, Wegovy, or Zepbound in the captured evidence.

Criteria SkinnyRx Embody
Starting price As low as $249/mo (oral tablets) $69/month semaglutide (was $299)
Form Daily oral semaglutide tablets Compounded semaglutide and tirzepatide injections
Shipping speed Free overnight shipping; tracking in 2 business days Free shipping; arrives in 1–2 days after approval
Support and monitoring Personalized care, ongoing provider support Telemed visits included, 24/7 support, fewer premium add-ons
Regulatory/testing Partner pharmacies run third-party testing; compounded drugs not FDA-approved Compounded meds not FDA-approved finished products

SkinnyRx vs Embody: final take and who should choose which

Both SkinnyRx and Embody are telehealth options that prescribe compounded GLP-1 medications after clinician review, but they are designed for different priorities. SkinnyRx focuses on an oral tablet format, FSA/HSA eligibility, and overnight shipping. Embody focuses on the lowest possible monthly cash price, fast 1–2 day delivery, and a no-frills telehealth model.

Start Embody at $69/mo

Compare SkinnyRx plans and FSA/HSA eligibility

Choose SkinnyRx if you want oral semaglutide with FSA/HSA flexibility and free overnight shipping. Choose Embody if lowest monthly pricing and fast 1–2 day shipping are your primary concerns. Both require an online consultation and clinician review before a prescription is provided, and both rely on compounded medications that are not FDA-approved finished products.

Ready to Compare GLP-1 Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.